https://www.uhhospitals.org/health-information/health-and-wellness-library/article/adult-diseases-and-conditions-v0/oral-medications
Oral Medicines for Type 2 Diabetes | University Hospitals
for type 2 diabetesoral medicinesuniversityhospitals
https://www.gov.uk/drug-safety-update/oral-anticancer-medicines-risk-of-incorrect-dosing
Oral anticancer medicines: risk of incorrect dosing - GOV.UK
Advice for healthcare professionals on potentially fatal outcomes of oral anticancer medicines if they are not prescribed, dispensed or administered properly.
anticancer medicinesoralriskincorrectdosing
https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-diuril-oral-solution-unlicensed-medicine-mawdsley-brooks-and-company-limited-el-21-a-slash-32
Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine), Mawdsley-Brooks &...
class 4
https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-diazepam-2mg-slash-5ml-oral-solution-sugar-free-el-21-a-slash-07-pl-0142-slash-0103
Class 4 Medicines Defect Information, Diazepam 2mg/5ml Oral Solution Sugar Free (EL (21)A/07) (PL...
Accord-UK Ltd have informed us that important safety warnings for the excipient Propylene glycol are missing from the patient information leaflet (PIL).
https://www.businesswire.com/news/home/20250106183505/en/Orbis-Medicines-Raises-EUR-90-Million-Series-A-Funding-Round-to-Develop-Pipeline-of-Oral-Macrocycles
Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles
Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the close of a EUR 90 million Series A funding round, bringing the total amount ...
https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-aripiprazole-1mg-ml-oral-solution-el-19-a-20
Class 2 Medicines Recall: Aripiprazole 1mg/ml oral solution (EL (19)A/20) - GOV.UK
Accord-UK Ltd is recalling the above batches due to the potential for small particles of Aripiprazole active material to be present which may affect the...
https://www.biospace.com/homology-medicines-announces-upcoming-oral-presentation-on-phenix-gene-therapy-clinical-trial-for-adults-with-pku
Homology Medicines Announces Upcoming Oral Presentation on pheNIX Gene Therapy Clinical Trial for...
Nov 5, 2020 - Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the upcoming oral presentation of data from the dose-escalation portion...
https://www.cochrane.org/de/evidence/CD013206_which-oral-or-injected-medicines-work-best-treat-moderate-severe-eczema
Which oral or injected medicines work best to treat moderate to severe eczema? | Cochrane
https://www.cochrane.org/evidence/CD013206_which-oral-or-injected-medicines-work-best-treat-moderate-severe-eczema
Which oral or injected medicines work best to treat moderate to severe eczema? | Cochrane